Oct 6 2017

Shionogi Pharma Media and Investor Relations – Investor Relations #sun #pharma

#shionogi pharma


Investor Relations

About Shionogi Pharma, Inc.
Shionogi Pharma, Inc. (formerly Sciele Pharma, Inc.), is a US-based group company of Shionogi & Co. Ltd, based in Atlanta, Georgia specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Diabetes, Women’s Health and Pediatrics. The Company’s Cardiovascular/Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and type 2 diabetes; its Women’s Health products are designed to improve the health and well-being of women and mothers and their babies; and its Pediatrics products treat allergies, asthma, head lice infestations, and attention deficit/hyperactivity disorder (ADHD).

About Shionogi & Co. Ltd.
Shionogi & Co. Ltd. headquartered in Osaka, Japan, is a major research-driven pharmaceutical company dedicated to placing the highest value on patients. Shionogi’s Research and Development currently targets three therapeutic areas: Infectious Diseases, Pain, and Metabolic Syndrome. The Company has provided such innovative medicines as Crestor and Doripenem, which have been successfully delivered to millions of people who need them. In addition, Shionogi is engaged in some new research areas such as allergy and cancer. Contributing to the health of patients around the world through development in these therapeutic areas is Shionogi’s primary goal. For more details, please visit

Tokyo Stock Exchange (4507)

Featured Reports and Presentations

Sciele Pharma Recent News

Five Concourse Parkway Suite 1800
Atlanta, Georgia 30328
Phone: (800) 461-3696

© 2010 Shionogi Pharma, Inc.
GEN-WEB-04 Rev. 01/10

Written by admin

Leave a Reply

Your email address will not be published. Required fields are marked *